Chong Kun Dang enters the 'ADC' market

K-bio’s workforce issues

K-bio scramble to get approval for biosimilars

Expectations for world's first multi-target stroke..

Conglomerates launch with different goals

Korean government to provide financial support for..

The Future of Drug Delivery Platform, MDimune Inc.

The Autoimmune Specialists’ CRO with State-of-the-..

The global leader in exosome-based therapeutics, I..

BIO INSIDER EPISODE 17"Birth of K-brand throu..

BIO INSIDER 15편. '"암 진단에서 치료까지 토탈 솔루션 구축&quo..

BIO INSIDER 14편. '세포치료제의 대중화' 셀라퓨틱스바이오 김경규 대표

Official highlights of BIOPLUS-INTERPHEX KOREA 202

2023 바이오산업의 날 현장 스케치 영상

2023 바이오산업의 날 개막영상

Official highlights of BIOPLUS-INTERPHEX KOREA 202

[한국바이오협회]바이오인턴십 19기 브이로그

GMP교육 VLOG - 경북바이오산업연구원편